Summit Therapeutics (NASDAQ:SMMT) reported quarterly earnings results on February 23, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.14, missing the consensus estimate of $-0.10 by $0.04 per share. Revenue came in at , missing the estimate of $56.8M.
Summit Therapeutics's stock moved following the earnings release. The stock currently trades at $16.41 with a market capitalization of $13.4B.
FEATURED BY
Learn how to invest in the specific type of private investment that netted Warren Buffett a combined $27 Billion in profits.
Enter Your Email Below To Get The Details
By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works
Take a moment right now and unlock this shocking video.
I just saw this from my friend, veteran trader Tim Bohen.
He says this video details a mega trading opportunity right now, that could blow up in the weeks to come.
In fact, he says, just one tweet from Elon Musk could blow this story wide open on or before April 25.
Enter Your Email Below To Unlock The Video
By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works
It’s called the “Forever Battery” and this groundbreaking technology could be the biggest story of 2022. Get the details on how to invest in this exciting startup from early-stage investing expert Charles Mizrahi.
Enter Your Email Below To Watch The Free Presentation Revealing the Name & Ticker
By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works
Adoption of “Imperium” is set to happen faster than the internet in the 90’s. One $2 stock is positioned to cash in on the explosive growth.
Enter Your Email Below To Get The Name & Ticker of The $2 Stock At The Center Of The “Imperium” Breakthrough
By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works
Blockchain technology burst into the mainstream in 2021. Institutional investors have been pouring money into a variety of highly promising opportunities, but one investment stand out as the single biggest blockchain opportunity.
Enter Your Email Below To Watch Jeff Brown’s Free Presentation Revealing the #1 Blockchain Investment of 2022
By submitting your email address, you give Smart Investor's Daily permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works